May 1, 2010

Angiotensin Blockade Is Associated With Early Graft Dysfunction After Live Donor Renal Transplantation


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

Many patients pre-transplant are prescribed ACE-inhibitors or angiotensin-receptor blockers for their antihypertensive and cardiovascular benefits, but they may have adverse renal hemodynamic effects. In this single-centre cohort study, living kidney donor recipients who were on an ACE-I or ARB pre-transplant had a slower fall in serum creatinine post-transplant. This is a small study, but could lead to changes in practice for living donor recipients if borne out by larger studies.

Renal Transplantation